Nu-Med Plus, Inc. (NUMD): Capital Expenditures

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2014-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2019-12-31
$28.9K2012-12-31: $18.8K2013-12-31: $28.9K2014-12-31: -$1.1K2015-12-31: $02017-12-31: $02018-12-31: -$5.0K2019-12-31: $0$0
2012-12-31 Capital Expenditures (USD) 2019-12-31
Period endedCapital ExpendituresChange YoYSource filing
2019-12-31$0n/m2020-03-30, From 2019-01-01
2018-12-31-$5.0Kn/a2020-03-30, From 2018-01-01
2017-12-31$0n/a2019-04-01, From 2017-01-01
No annual figure between 2015-12-31 and 2017-12-31.
2015-12-31$0n/m2016-04-13, From 2015-01-01
2014-12-31-$1.1Kn/c2016-04-13, From 2014-01-01
2013-12-31$28.9K+53.8%2015-03-23, From 2013-01-01
2012-12-31$18.8Kn/a2014-02-21, From 2012-01-01